Neurofibromatosis type 1: Psychiatric disorders and quality of life impairment;Neurofibromatose de type 1: Troubles psychiatriques et altération de la qualité de vie

Presse Medicale

Volumn 35, Issue 2 II, 2006, Pages 277-280

  Belzeaux, Raoul ^a,b   Lançon, Christophe ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BIPOLAR DISORDER; DEPRESSION; DYSTHYMIA; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; MOOD DISORDER; NEUROFIBROMATOSIS; PERSONALITY DISORDER; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SUICIDE;

EID: 33344465645     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74570-5     Document Type: Article

References (18)

1. Wolkenstein P, Zeller J, Ismaïli N. Neurofibromatoses. Encycl Méd Chir Dermatologie. 2002; 98-755-A-10, 10 p.
2. Pinson S, Wolkenstein P. La neurofibromatose de type 1 ou maladie de Von Recklinghausen. Revue de Médecine Interne. 2005; 26: 196-215.
3. NIH Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol. 1988; 45: 575-8.
4. Samuelsson B, Riccardi VM. Neurofibromatosis in Gothenburg, Sweden III. Psychiatric and Social Aspect. Neurofibromatosis. 1989; 2: 84-106.
5. Zöller M E T, Rembeck B. A psychatric 12-year follow up of adult patients with neurofibromatosis type 1. Journal of Psychiatric Research. 1999; 33: 63-8.
6. Harris EC, Barraclough M. Suicide as an Outcome for Medical Disorders. Medecine. 1994 Nov; 73: 281-96.
7. Cnossen MH, Goede-Bolder A de, van den Broeck KM. A prospective 10-year follow up study of patients with neurofibromatosis type 1. Arch Dis Child. 1998; 78: 408-12.
8. Mouridsen SE, Sorensen SA. Psychological aspect of von Recklinghausen neurofibromatosis (NF1). J Med Genet. 1995; 32: 921-4.
9. Mauger D, Zeller J, Revuz J, Wolkenstein P. Retentissement psychologique de la NF1: analyse en vue d'une évaluation de la qualité de vie. Ann Dermatol Venereol. 1999; 126: 619-20.
10. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplège A. Quality-of-life impairment in Neurofibromatosis type 1. Arch Dermatol. 2001; 137: 1421-5.
11. Albon J. Gender response to neurofibromatosis 1. Soc Sci Med. 1996; 42: 99-109.
12. Riccardi VM, Kleiner B. Neurofibromatosis: a neoplasticbirth defect with two age peaks of severe problems. Birth Defects Orig Artic Ser. 1977; 13: 131-8.
13. Mantelet S. Donnée épidémiologique concernant les comorbidités dépression-maladies organique. In: Lempérière T et al. Dépression et Comorbidités Somatiques. Paris: Masson (Acanthe), 2003. p. 3-17.
14. Gupka MA, Gupka AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003; 4: 833-42.
15. Dociu I. Aspect socio-professionnels chez les malades atteints de neurofibromatose de Recklinghausen. Encéphale. 1972 Mar-Apr; 61 :117-26.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, 1987.
17. Rouillon F, Gorwood P. Épidémiologie des maladies mentales, Encyclopédie Médico-Chirurgicale, Traité de Psychiatrie, 37-878-A-10, 1996.
18. Granger B. La psychiatrie d'aujourd'hui. Paris: Odile Jacob; 2003.